RG
CBST

Redmile Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Redmile Group’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-283,756
Closed -$18.8M – 70
2014
Q3 		$18.8M Buy
+283,756
New +$18.6M 2.17% 18
2013
Q4 		– Sell
-452,600
Closed -$28.8M – 70
2013
Q3 		$28.8M Buy
+452,600
New +$27.4M 4.33% 5

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group's CBST Position: Q4 2014 in Review

Redmile Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 283,756 shares — an estimated $18.8M sold.

Redmile Group first reported a position in CBST in Q3 2013 and held it in 2 quarters. The position peaked at $28.8M in Q3 2013. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Redmile Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Redmile Group sold 283,756 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $18.8M.
  • Redmile Group first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
  • Redmile Group's CUBIST PHARMACEUTICALS INC position peaked at $28.8M in Q3 2013.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Redmile Group's 13F filing for Q4 2014, filed 18 Feb 2015.